We are live on ! Find out more
RVMD icon

Revolution Medicines
RVMD

184 hedge funds and large institutions have $4.64B invested in Revolution Medicines in 2023 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 81 increasing their positions, 34 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

138% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 34

87% more call options, than puts

Call options by funds: $19.1M | Put options by funds: $10.2M

50% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 36

49% more capital invested

Capital invested by funds: $3.11B → $4.64B (+$1.52B)

44% more funds holding in top 10

Funds holding in top 10: 9 → 13 (+4)

10% more funds holding

Funds holding: 168 → 184 (+16)

4.28% less ownership

Funds ownership: 102.97% → 98.68% (-4.3%)

Holders
184
Holders Change
+16
Holders Change %
+9.52%
% of All Funds
2.68%
Holding in Top 10
13
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+44.44%
% of All Funds
0.19%
New
54
Increased
81
Reduced
34
Closed
36
Calls
$19.1M
Puts
$10.2M
Net Calls
+$8.88M
Net Calls Change
+$5.64M

Top Buyers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
+$127M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$120M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$104M
4
BlackRock
BlackRock
New York
+$98.1M
5
CC
Casdin Capital
New York
+$93.8M

Top Sellers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
-$131M
2
CG
Column Group
California
-$29.6M
3
AG
Artal Group
Luxembourg
-$20M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$16.7M
5
APM
Avidity Partners Management
Texas
-$14.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PWMG
176
Private Wealth Management Group
New Jersey
$1.03K +$865 +36 New
NA
177
NewEdge Advisors
Louisiana
$602 – – –
S
178
SignatureFD
Georgia
$488 -$2.55K -106 -86%
JWA
179
JFS Wealth Advisors
Pennsylvania
$345 -$216 -9 -43%
AssetMark Inc
180
AssetMark Inc
California
$172 +$144 +6 New
SIC
181
SJS Investment Consulting
Ohio
$115 -$96 -4 -50%
AF
182
Advisornet Financial
Minnesota
$115 -$72 -3 -43%
DPW
183
DiNuzzo Private Wealth
Pennsylvania
$87 +$72 +3 New
Osaic Holdings
184
Osaic Holdings
Arizona
$28 -$240 -10 -91%
Millennium Management
185
Millennium Management
New York
– -$5.95M -247,816 Closed
DCM
186
Driehaus Capital Management
Illinois
– -$6.04M -218,153 Closed
Squarepoint
187
Squarepoint
New York
– -$3.25M -117,302 Closed
Walleye Capital
188
Walleye Capital
New York
– -$2.64M -95,517 Closed
SCM
189
Sio Capital Management
New York
– -$2.01M -72,700 Closed
CSS
190
Cubist Systematic Strategies
Connecticut
– -$1.76M -63,475 Closed
PMEF
191
Point72 Middle East FZE
United Arab Emirates
– -$1.71M -61,835 Closed
EGM
192
Engineers Gate Manager
New York
– -$1.5M -54,082 Closed
SEC
193
Seven Eight Capital
New York
– -$1.22M -44,247 Closed
Hudson Bay Capital Management
194
Hudson Bay Capital Management
Connecticut
– -$1.19M -43,095 Closed
YIH
195
Y-Intercept (HK)
Hong Kong
– -$860K -31,065 Closed
National Bank of Canada
196
National Bank of Canada
Quebec, Canada
– -$755K -30,783 Closed
Adage Capital Partners
197
Adage Capital Partners
Massachusetts
– -$830K -30,000 Closed
DTL
198
Dynamic Technology Lab
Singapore
– -$698K -25,208 Closed
GCM
199
Ghisallo Capital Management
Massachusetts
– -$692K -25,000 Closed
JGC
200
J. Goldman & Co
New York
– -$613K -22,135 Closed
5 6 7
8
9

RVMD Hedge Fund Activity: Q4 2023 in Review

184 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Revolution Medicines (RVMD) for Q4 2023, worth a combined $4.64B — up 49% from $3.11B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new RVMD positions and 36 closed out — a net gain of 18 holders — while 81 added to existing stakes and 34 trimmed.

The largest buyer was Alphabet Inc, opening a new position worth an estimated $127M. The largest seller was EcoR1 Capital, cutting an estimated $131M.

  • 184 institutional investors held Revolution Medicines (RVMD) as of Q4 2023, up from 168 in Q3 2023.
  • Funds reported $4.64B of Revolution Medicines stock for Q4 2023, up 49% quarter-over-quarter.
  • 54 funds opened new Revolution Medicines positions in Q4 2023 and 36 closed out, a net change of +18 holders.
  • The largest Revolution Medicines buyer in Q4 2023 was Alphabet Inc, an estimated $127M added.
  • The largest Revolution Medicines seller in Q4 2023 was EcoR1 Capital, an estimated $131M sold.

Based on aggregated 13F filings for Q4 2023.